Key Summary Points {#FPar1}
==================

Laryngeal sarcomas constitute an extremely rare entity among head and neck malignancies.Osteosarcoma of the larynx is typically a highly malignant neoplasm that metastasizes early, has a propensity of hematogenous spread and also has a marked tendency to recur.A full photomicrographic documentation is essential for the diagnosis and registration of osteosarcoma cases.The diagnosis of this highly malignant tumor would preferably warrant an international consultation network including a registry of rare head and neck neoplasms.

Introduction {#Sec1}
============

Despite being the most common primary malignant neoplasm of the bony skeleton, osteosarcoma is one of the rarest malignant mesenchymal neoplasms of the larynx. Sarcomas encountered in the larynx are usually chondrosarcomas. Therefore, even physicians in referral-based academic centers of pathology or otorhinolaryngology--head and neck surgery may encounter only a single patient with a true laryngeal osteosarcoma in their entire career. Of note, we searched the REFCOR database (réseau d'Expertise Français sur les Cancers ORL Rares \[French Network of Rare Head and Neck Tumors\]) in order to find cases to report in the present review. The REFCOR has been registering rare head and neck cancers, i.e., rare cancers of the aerodigestive tract excluding squamous cell carcinoma and undifferentiated nasopharyngeal carcinoma, and cancers of the salivary glands, ear, nasal cavities, and sinus, since 2008. Out of the 7530 patients registered up to August 2019, only 54 osteosarcoma cases were diagnosed, and none of these was located in the larynx.

Laryngeal osteosarcoma was first described by Jackson and Jackson in 1942 without histological documentation \[[@CR1]\]. In 1946, Clerf et al. reported eight cases of sarcoma of the larynx, and one of these was classified as fibro-osteosarcoma, but the photomicrograph of the tumor was not convincing \[[@CR2]\]. The first well-documented case of laryngeal osteosarcoma was described by Sprinkle et al. in 1966 \[[@CR3]\]. Of note, in 1974, the textbook *Tumors of the Head and Neck: Clinical and Pathological Considerations* by Batsakis concluded that no authentic case of osteosarcoma in the upper respiratory tract, including the larynx, had been reported at that time \[[@CR4]\]. In 2017, Bennion et al. reported 33 laryngeal osteosarcomas having been reported in the English literature since 1942, but many of the reports listed in their review, including their own cases, did not present pathological documentation \[[@CR5]\].

It is noteworthy that morphological features of sarcomas typically represent a heterogeneous variation in morphology. This will lead to challenging differential diagnostic considerations, especially when the obtained biopsies remain small. In contrast to a low-grade chondrosarcoma---in which a limited biopsy specimen may still leave open the question of the malignant nature of that lesion---it is usually quite apparent for the pathologist that a laryngeal osteosarcoma specimen represents a high-grade malignancy. More importantly, the precise subclassification of the malignancy will need to be determined.

The existing reports of laryngeal osteosarcoma cases do not consistently include pathological documentation that would allow critical evaluation of the final pathological diagnosis. Therefore, our primary aim was to create a current series of all the published laryngeal osteosarcoma cases by critically evaluating the published reports of this rare malignancy and to include only those cases with adequate pathological description of the findings. The secondary aim was to obtain comprehensive information regarding the characteristics of these neoplasms to enable a discussion of possibilities for enhancing their diagnostic accuracy.

Methods {#Sec2}
=======

We conducted a literature search in the PubMed database using the following keywords: "Laryngeal" OR "Larynx" AND "Osteosarcoma". The search covered all years from the origin of the database until 31 December 2019. The Preferred Reporting Items for Systematic Review and Meta-Analysis (<https://www.equator-network.org/>) methodology was applied. A total of 61 hits were retrieved (Fig. [1](#Fig1){ref-type="fig"}). Of these, 30 publications were relevant as having reported a new case/s of laryngeal osteosarcoma (*N* = 33) that met the inclusion criteria of providing proper pathological evaluation and photomicrographic documentation of the finding. Cases that did not meet these inclusion criteria were excluded. This article is based on previously conducted studies and does not contain any studies with human participants or animals performed by any of the authors.Fig. 1Flow chart describing the PRISMA search

Results and Discussion {#Sec3}
======================

Clinical Features of the Reported Cases in the Literature {#Sec4}
---------------------------------------------------------

Many reports indicate that this neoplasm occurs in men in their sixth and eighth decades of life, and that the lesion is not directly associated with alcohol or tobacco exposure \[[@CR6], [@CR7]\]. Laskin et al. and Sheen et al. reported two patients with a history of radiotherapy prior to the development of laryngeal osteosarcoma \[[@CR8], [@CR9]\]. These tumors usually arise from the vocal cord and cricoid cartilage. Therefore, the most common symptoms are hoarseness, dyspnea, and obstruction. The tumors included in this review and with information on the exact location (*N* = 22) involved either subglottic \[[@CR2]\], supraglottic \[[@CR3]\] or transglottic \[[@CR2]\] structures, vocal cords \[[@CR10]\], or thyroid and/or cricoid cartilages \[[@CR6]\].

Osteosarcoma is typically a highly malignant neoplasm that metastasizes early, with a propensity for hematogenous spread and also a marked tendency to recur. There are reports of metastases to regional lymph nodes, but these remain rare, and instead, hematogenous spread to the lungs is the main route. In the present review, 12 out of the 33 patients were diagnosed with distant metastases, most frequently in the lungs. Seventeen out of the 25 patients with follow-up data available in the published case reports had experienced persistent or early recurrent disease, typically within 1--2 years.

Pathology of Laryngeal Osteosarcoma {#Sec5}
-----------------------------------

Macroscopically, the neoplasm is mainly polypoid or exophytic in appearance but may also mimic other sarcomas. The gross specimen is typically grainy and, in some areas, difficult or impossible to cut with a scalpel because of its ossification. The tissue may have a variable color ranging from yellow to brown or red.

Microscopically, the tumor is composed of frankly malignant, spindle-shaped mesenchymal cells, associated with osteoid and immature neoplastic bone formation, as was shown in the reviewed reports (Fig. [2](#Fig2){ref-type="fig"}). The nuclei show considerable hyperchromasia or pleomorphism, and mitoses may be numerous. Atypical and bizarre giant cells and multinucleated osteoclast-like cells have been described. Venous invasions may be identified.Fig. 2**a** Laryngeal osteosarcoma with osteoid formations (arrow) produced by malignant cells (hematoxylin--eosin). **b** Osteoid formation (arrows) by the tumor cells is readily apparent and confirms the diagnosis of osteosarcoma (hematoxylin--eosin). **c** Another area of the tumor-producing osteoid (arrows) (hematoxylin--eosin)

Immunohistochemical staining has shown that the neoplasm is positive for vimentin and negative for desmin, S-100 protein, cytokeratin (AE1/AE3, MNF-116, CK5/6, CK7, CK8, CK19, CK20), and epithelial membrane antigen. Both osteonectin and osteocalcin are expressed in osteogenic sarcoma but are not sufficiently specific. However, osteonectin and osteocalcin will highlight osteoid matrix and distinguish it from collagen matrix.

Electron microscopy studies \[[@CR10]--[@CR12]\] have shown cells resembling osteoblasts with pleomorphic nuclei and nucleoli of variable size within the abundant cytoplasm containing numerous dilated cisternae of rough endoplasmic reticulum. The cells were enveloped by interlacing collagen fibers. Osteoblastic elements predominated but cartilaginous and fibrous tissue could also be found. No desmosomes or other evidence of epithelial differentiation was found in the tumor.

Diagnosis of Laryngeal Osteosarcoma {#Sec6}
-----------------------------------

The definite diagnosis of osteosarcoma depends on the identification of osteoid production by malignant cells in the biopsy sample, as was shown in the reviewed reports. The differential diagnosis includes spindle-cell squamous carcinoma with osteoid differentiation, chondrosarcoma, malignant fibrous histiocytoma, fibrosarcoma, and myositis ossificans affecting the larynx. Spindle-cell squamous carcinoma may contain benign and rarely malignant osteoid areas \[[@CR13]\]. Therefore, older reports of laryngeal osteosarcoma may represent spindle-cell squamous carcinoma with osteoid formation. Any bone-producing malignant mesenchymal lesion should at first be suspected as a spindle-cell carcinoma. The presence of islands of carcinoma in situ or microinfiltrating carcinoma excludes the diagnosis of osteosarcoma.

In osteogenic sarcoma, clearly sarcomatous areas are present, and the "zonal phenomenon"---which is characterized by a central cellular area, an intermediate zone of osteoid formation, and a peripheral shell of highly organized bone---is absent. The phenomenon of formation of mature bone is most prominent in the periphery of the lesion and is an important criterion for differentiating myositis ossificans from osteogenic sarcoma. In this latter lesion, mature osteoids are located in the center of neoplasm, and neoplastic mesenchymal cells---that form the osteoids---are in the periphery.

Osteogenic sarcoma metastatic to larynx has also been reported \[[@CR14], [@CR15]\]. This unlikely event can be ruled out with clinical assessment of the patient.

Treatment and Prognosis {#Sec7}
-----------------------

Wide local resection with clear margins, which typically warrants total laryngectomy, remains the treatment of choice for laryngeal osteosarcoma to achieve local control and long-term survival. In the present cases, laryngectomy was performed for 26 out of the 29 cases with treatment-related data available. Adjuvant radiotherapy needs to be considered individually, as osteosarcomas are relatively radioresistant. Chemotherapy might improve the prognosis for patients with disseminated lesions, and it should be emphasized that in the results of the present review, the number of patients with distant metastasis was high (36%).

In the present review, five out of the 33 patients had no reported follow-up data. Eleven out of the 28 patients with follow-up data available were alive with no evidence of disease after a variable follow-up time (range 9 months to 8 years).

The important features of laryngeal osteosarcoma are summarized in Table [1](#Tab1){ref-type="table"}. A summary of the reported laryngeal osteosarcoma cases is shown in Table [2](#Tab2){ref-type="table"}, with the first case published in 1966 \[[@CR3]\] and the last in 2019 \[[@CR38]\]. Table [3](#Tab3){ref-type="table"} provides a description of the cases that have been reported without pathological documentation.Table 1Key features of laryngeal osteosarcomaRarityDemographics Large lesions arising predominantly in men in their sixth to eight decadesHistology High-grade sarcoma with area of osteoid production by the tumor cells at least focally Chondroid elements may be present, as may areas reminiscent of fibrosarcoma, malignant Fibrous histiocytoma, or sarcoma (not further subclassified) Immunohistochemical staining can be utilized and will add to the histological diagnosisDifferential diagnosis Spindle-cell squamous carcinoma with osteoid differentiation, chondrosarcoma, malignant fibrous histiocytoma, fibrosarcoma, and myositis ossificansPrognosis Laryngeal osteosarcoma usually results in death in less than 2 years from either extensive local disease or pulmonary metastasesTable 2Cases of laryngeal osteosarcoma with pathological documentationInstituteAuthorsYearCharacteristics and treatmentFollow-upUniversity of Washington, Seattle, WA, USAMantilla et al. \[[@CR38]\]201975/M. Former smoker. Progressive hoarseness. Anterior commissureLost to follow-upHigh-grade. No invasion of TC. No Metastasis. LERashid Hospital, DubaiAbdullGaffar and Keloth \[[@CR16]\]201832/F. Non-smoker. Hoarseness for 1.5 monthsLost to follow-upSubglottic, 1.5 cm. Small-cell OSChandigarh, IndiaBahl et al. \[[@CR6]\]201550/M. Hoarseness for 2 monthsNED at 9 monthsTransglottic. No metastases. LE, thyroidectomy, partial pharyngectomy. CTNicolaus Copernicus University, Torun, PolandSawicki et al. \[[@CR17]\]201558/F. Dyspnea for 6 monthsNED \> 22 monthsSubglottic. Immobile VC. No metastases. LETygerberg Hospital, Cape Town, South AfricaMosalleum et al. \[[@CR7]\]201555/M. Former smoker (2PY)Bilateral lung metastases at 8 monthsDysphonia, dyspnea for 4 months. LESaitama Medical University, International Medical Center, Hidaka, Saitama, JapanKuba et al. \[[@CR18]\]201555/M. Non-smoker. OdynophagiaNED at 20 monthsNeck massHigh-grade osteoblastic OSNo metastases. Partial LEBaroda, Gujarat, IndiaBhatt et al. \[[@CR19]\]201438/M. Smoker. Hoarseness for 2 months. No metastasesNED at 15 monthsNear-total LEIstanbul University, TurkeyUlusan et al. \[[@CR20]\]201259/M. Smoker. Hoarseness and dyspnea. Anterior commissureNED at 8 yearsRadiation-induced OS (RT 5 years earlier). Normal chest, abdominal, and bone radiographs. No metastasisLETabriz University Tabriz, IranSanaat et al. \[[@CR21]\]200971/M. Smoker. True and false cordsDOD at 12 monthsDyspnea, dysphagia, and odynophagiaSolid mass destroying both cords with supra- and subglottic extensionBone and lung metastases. LESisli Etfal Education & Research, Hospital, Department of Radiation Oncology, Istanbul, TurkeyArslan et al. \[[@CR22]\]200869/M. Larynx. NOS. Persistent hoarseness. LE and postoperative RT. Neck recurrence 5 months laterDODLung and neck metastasesHospital San Giovanni, di Dio e Ruggi d'Aragona, Via San Leonardo, Salerno, ItalyMottola et al. \[[@CR23]\]200856/M. Non-smoker. TC, CC, and paratracheal space. Dyspnea, dysphagia, and dysphonia. Tumor mass affecting glottis and supraglottis. LEDOD 3 monthsOddział Otolaryngologiczny Szpitala im. F. Raszei w PoznaniuRydzewki et al. \[[@CR24]\]2005Bilateral neck and lung metastases LE, ND, and CTDODUniversity of Texas, Southwestern Medical Center, Dallas, TX, USAAthré et al. \[[@CR25]\]200569/F. Progressive dyspnea. Larynx, strap muscles, and thyroid glandDOD at 10 monthsDystrophic calcification outside laryngeal confines. Total LE, pharyngectomy, esophagectomyLung metastasisDepartments of ORL and Pathology Okmeydanı Training Hospital, Istanbul, TurkeyTopaloglu et al. \[[@CR26]\]200480/M. RVC, LVC, and ventricular bands. Hoarseness, progressive dyspnea. Soft tissue mass narrowing the airway. Extended LENED 15 monthsM.D. Anderson Cancer Center, Houston, TX, USMadrigal et al. \[[@CR27]\]200250/M. RVC. Hoarseness. Partial frontolateral LENED at 24 months59/M. Smoker. TC. Hoarseness. Destructive lesion of the TC extending to parapharyngeal soft tissue. Total LE, CRT. Multiple lung metastasesDOD 18 at months60/M. Smoker. Polypoid mass of the RVC with anterior commissure extension. Dyspnea. LE and CRTNED at 60 monthsNeck recurrence 10 months later69/M. Smoker. True vocal cordLost to follow-upDyspnea, dysphonia, and coughLung metastasesOhio State University, OH, USARossi et al. \[[@CR28]\]199868/M. Former smokerDOD at 3 monthsWide-field LE. Lung metastasesThe Long Island Jewish Medical Center. The Long Island Campus of the Albert Einstein College of Medicine, New Hyde Park, NY, USAMyssiorek et al. \[[@CR29]\]199847/M. Smoker. TC. Hoarseness, dyspnea, otalgia, hemoptysisDOD at 12 monthsDestructive lesion of TC with extension into soft tissues.LE. Bone metastasisUniversity of Pittsburgh, Medical Center, Pittsburgh, PA, USABerge et al. \[[@CR30]\]199860/F. Non-smoker. CC. Dysphonia, dysphagia, and weight lossNED at 44 monthsExpansion of the medullary portion of the cricoid cartilage with encroachment on the airwayLE and NDNational Taiwan University Hospital, Taipei, TaiwanSheen et al. \[[@CR9]\]199756/M. RT for nasopharyngeal carcinoma 32 years earlierDOD at 21 monthsLeft neck and anterior TCHoarseness. Hyperdense mass in the left upper neck. LEInstitute AFIPDevaney and Ferlito \[[@CR31]\]1996Pathology consultation caseLost to follow-upHasharon Hospital, Golda Medical Center, Petah TikvaZohar et al. \[[@CR32]\]1996SurgeryLost to follow-upCentre Hospitalier Universitaire, de Bordeaux, FrancePinsolle et al. \[[@CR12]\]199065/M. Former smoker. Dyspnea, dysphonia. 1.5 cm polypoid tumor involving the RVC and anterior commissure. RTNED at 60 monthsRecurrence after 1 monthResection and pectoralis flapUniversity of Liverpool, EnglandVan Laer et al. \[[@CR33]\]198975/M. LVC and left pyriform fossaRecurrence at 13 monthsDysphagia, discomfort in the throatAmorphous mass of calcification. LEPathologisches Institut Oldenburg, GermanyRemagen et al. \[[@CR34]\]198365/M. LVC. RT. Recurrent diseaseDOD at 24 monthsMayo Clinic, Rochester, NY, USAGorenstein et al. \[[@CR35]\]198075/M. RVC and ventricleDOD at 14 monthsHoarseness 5 months. LE and NDLocal and distant metastasesMahidol University, Bangkok, Thailand,Suchatlampong et al. \[[@CR11]\]198167/M. LVC, anterior and posterior commissure and supraglottisDOD at 6 monthsHoarseness and dyspnea. Mass involving the glottis with supraglottic extension. RTUniversity of Texas, Southwestern Medical School, Dallas, TX, USADahm et al. \[[@CR10]\]197879/M. RVC and anterior commissureDODHoarseness and difficulty breathingPolypoid mass occupying the airwayMultiple lung metastases. LEState Univ. of New York, Buffalo, NY, USAHaar et al. \[[@CR36]\]197866/M. Smoker. Hoarseness. CC, posterior wall of the proximal trachea and displacing the esophagus anteriorlyDOD at 21 monthsLung metastasis. LERoyal Victoria Infirmary, Newcastle, UKMorley et al. \[[@CR37]\]197362/M. Hoarseness, dyspnea, acute respiratory obstruction. Occasions of loss of consciousness. Polypoid lesion of RVCDOD at 3 monthsLVC with supraglottic extensionSubtotal LE and RTUniv. of Virginia, Charlottesville, VA, USASprinkle et al. \[[@CR3]\]196671/M. Hoarseness. Posterior surface of RVC. No metastasis. LENED \> 24 months*F* female, *M* male, *OS* osteosarcoma, *LE* laryngectomy, *ND* neck dissection, *Tx* treatment, *NED* no evidence of disease, *PY* pack years, *RT* radiotherapy, *CT* chemotherapy, *CRT* chemoradiotherapy, *DOD* dead of disease, *TC* thyroid cartilage, *CC* cricoid cartilage, *RVC* right vocal cord, *LVC* left vocal cord, *ND* neck dissectionTable 3Reported cases of laryngeal osteosarcoma with no pathological documentationBennion et al. \[[@CR5]\]201748/F. Shortness of breath. Erythematous mass inferior to the level of the true vocal cords at the posterior commissure. The tumor appeared to arise from the cricoid cartilage in computed tomography imaging. No microphotographyLaskin et al. \[[@CR8]\]198856/M. Three years after radiotherapy. No follow-up data. No microphotographyClerf et al. \[[@CR2]\]194651/M. Hoarseness and dyspnea. Later with local recurrence and lung metastasis. DOD 14 months. Pathological documentation not convincingJackson and Jackson \[[@CR1]\]194251/M. Hoarseness, dyspnea, and dysphagia. Cricoid cartilage. Local recurrence after 3 months. DOD after 6 months with mediastinal metastasis. No other data available*F* female, *M* male, *DOD* dead of disease

Conclusions {#Sec8}
===========

True laryngeal osteosarcoma remains an extremely rare malignancy. The true incidence of this entity is not known but based on the number of existing well-documented cases (*n* = 33) in the literature during 1966--2019, it is obviously not encountered at most of the institutions managing laryngeal tumors.

The diagnosis of this highly malignant tumor would preferably warrant an international consultation network including a registry of rare head and neck neoplasms. Electronic platforms for such activities exist. Our review demonstrates that full photomicrographic documentation is essential for the diagnosis and registration of osteosarcoma cases. Furthermore, such a collaborative effort would enable multidisciplinary recommendations for individual management as well. Naturally, management of laryngeal osteosarcoma should be centralized to a few experienced tertiary care academic centers.

This article was written by members and invitees of the International Head and Neck Scientific Group (<http://www.IHNSG.com>).
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